| | | | | |
| $31,8010 | +0,13 % | $280,50M | $11,54K | |
DBL DOUBLELINE OPPORTUNISTIC CREDIT FUND | $14,0950 | +0,04 % | $280,16M | $27,23K | |
TSI TCW Strategic Income Fund, Inc. | $4,3750 | +0,34 % | $279,70M | $169,85K | |
PAII Pyrophyte Acquisition Corp. II | $10,2650 | +0,05 % | $279,21M | $21,00 | |
| $13,9510 | -4,64 % | $279,07M | $227,20K | |
YDES YD Bio Limited Ordinary Shares | $4,6450 | -0,96 % | $279,07M | $12,22K | |
XCBE X3 Acquisition Corp. Ltd. Class A Ordinary Shares | $9,9940 | +0,04 % | $278,71M | $16,00 | |
RWAY Runway Growth Finance Corp. Common Stock | $6,5550 | -1,28 % | $278,70M | $186,03K | |
JILL J.Jill, Inc. Common Stock | $20,1560 | -0,27 % | $278,69M | $22,30K | |
LCTX Lineage Cell Therapeutics, Inc. | $1,0850 | +0,46 % | $278,19M | $446,41K | |
AXIN Axiom Intelligence Acquisition Corp 1 Class A Ordinary Shares | $10,3150 | +0,05 % | $278,12M | $12,86K | |
ACV Virtus Diversified Income & Convertible Fund | $26,6140 | -0,14 % | $278,09M | $4,34K | |
ALXO ALX Oncology Holdings Inc. Common Stock | $1,9950 | -2,21 % | $277,93M | $137,14K | |
| $1,3950 | -2,45 % | $277,83M | $163,55K | |
YSG Yatsen Holding Limited American Depositary Shares, each representing twenty (20) Class A Ordinary Shares | $3,0050 | +0,17 % | $277,66M | $36,72K | |
